Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vande Berg, B. C.
Right arrow Articles by Maldague, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vande Berg, B. C.
Right arrow Articles by Maldague, B. E.

Radiology, Vol 201, 519-523, Copyright © 1996 by Radiological Society of North America

ARTICLES

Sequential quantitative MR analysis of bone marrow: differences during treatment of lymphoid versus myeloid leukemia

BC Vande Berg, L Michaux, JM Scheiff, J Malghem, FE Lecouvet, MP Bourgois, A Ferrant, JL Michaux and BE Maldague
Department of Radiology and Medical Imaging, St Luc University Hospital Brussels, Belgium.

PURPOSE: To assess the use of bulk T1 measurements with magnetic resonance (MR) imaging for monitoring treatment response in leukemic patients, with separate analysis of patients with acute lymphoid (ALL) and those with acute myeloid leukemia (AML). MATERIALS AND METHODS: Bulk T1 values were determined repeatedly during the first 4 weeks of treatment in 16 patients with ALL (age range, 16-72 years) and the first 6 weeks of treatment in 51 patients with AML (age range, 17-75 years). Bulk T1 values were compared in all patients with AML or ALL and in those who did or did not respond to treatment. RESULTS: MR imaging of lumbar bone marrow demonstrated statistically significant differences in initial bulk T1 values and in changes in bulk T1 values during treatment between patients with ALL and those with AML. Changes in bulk T1 after the 2nd week of treatment were statistically significantly different between patients with and those without a response who had ALL but not in those with AML. CONCLUSION: Sequential quantitative MR imaging during treatment appears valuable for prediction of response in patients with ALL but not in those with AML. Further investigations are needed to determine what influence MR imaging can have on patient care, but patients with ALL should be analyzed separately from those with AML.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
L. S. Steinbach
"MRI in the Detection of Malignant Infiltration of Bone Marrow"--A Commentary
Am. J. Roentgenol., June 1, 2007; 188(6): 1443 - 1445.
[Full Text] [PDF]

Home page
 RadiologyHome page
A. Stäbler, A. B. Doma, A. Baur, A. Krüger, and M. F. Reiser
Reactive Bone Marrow Changes in Infectious Spondylitis: Quantitative Assessment with MR Imaging
Radiology, December 1, 2000; 217(3): 863 - 868.
[Abstract] [Full Text]

Home page
 BloodHome page
L. A. Moulopoulos and M. A. Dimopoulos
Magnetic Resonance Imaging of the Bone Marrow in Hematologic Malignancies
Blood, September 15, 1997; 90(6): 2127 - 2147.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1996 by the Radiological Society of North America.